Articles On IDT Australia (ASX:IDT)

Title Source Codes Date
Here’s what IDT Australia’s (ASX:IDT) 1H FY21 numbers are conveying

Source: Shutterstock Summary IDT has posted a net profit of $1.12 million in 1H FY21. During the reported period, IDT continued to operate as an essential service throughout the Victorian lockdowns. IDT’s share price has closed flat...

Kalkine Media IDT 1 week ago
Three healthcare stocks with stellar returns in 2020

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

Kalkine Media IDT 2 months ago
Pot stocks look to launch new products following yesterday’s TGA ruling

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

Stockhead IDT 5 months ago
ASX cannabis shares continue progress despite pandemic

ASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the Australian medical marijuana companies have been working through COVID-19 disruptions as they look to scale their businesses. Some have bee...

Motley Fool IDT 6 months ago
ASX cannabis shares adjust to coronavirus environment

Cannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the Australian medicinal cannabis industry grows, ASX cannabis companies are refining their strategies. While some are focused on cultivation a...

Motley Fool IDT 7 months ago
Check up: Making it in America

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 66 were in positive territory over the last fortnight, 18 were flat and 47 saw t...

Stockhead IDT 9 months ago
Cann to supply medicinal cannabis products to EU and UK, IDT will manufacture

Australian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medicinal cannabis-formulated oil and dried flower products to markets in the United Kingdom and European Union. The first deal is with UK-based...

SmallCaps IDT 9 months ago
Trading Places: This shareholder invested $150k in Predictive Discovery and made $2m

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve keen keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Stockhead IDT 10 months ago
18 Share Tips – 13 April 2020

Tom Bleakley, BW Equities BUY RECOMMENDATIONS IDT Australia (IDT) Chart: Share price over the year IDT is an Australian pharmaceutical company, with extensive experience in developing and producing high potency and high containment products...

TheBull IDT 10 months ago
This is what being on a ‘war footing’ against COVID-19 looks like

Before 1942, Australia hadn’t fully come to terms with what a world war would require it to do. By the end of 1942, after the Japanese Imperial airforce bombed Darwin, the country was a very different place. It had gone from a tiny populati...

Stockhead IDT 11 months ago
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

Stockhead IDT 1 year ago
How did ASX cannabis shares perform this reporting season?

Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c...

Motley Fool IDT 1 year ago
Cann Group shares wilt 5% on half year operating loss

The Cann Group Ltd (ASX: CAN) share price has plunged 5.15% in early trade after the cannabis cultivator released its half year results last night. Cann Group reported a loss for the half year, but is seeking to transition to near-term pro...

Motley Fool IDT 1 year ago
Winner’s Column: A tech firm, a goldie and a cannabis company dominate January’s Top 50

Following a 30 per cent gain in 2019, the S&P/ASX Emerging Companies index – which measures overall performance of the ASX microcap sector — moved another 3 per cent higher in January. Of the sub-$400m market cap companies on our list,...

Stockhead IDT 1 year ago
Why these 3 ASX cannabis shares are flying high in 2020

ASX cannabis shares endured a tough 2019, as investors cooled on the latest investing trend. However, some of the biggest listed groups have bounced back in January and are up as much as 100% this year. Here’s why 3 of the biggest names in...

Motley Fool IDT 1 year ago
Why these ASX shares are up over 30% already in 2020

The All Ordinaries index has started 2020 in an exceptionally positive fashion. The year may be just a touch over four weeks old, but the index has already carved out a gain of 5.8%. Whilst this is impressive, a number of shares on the ind...

Motley Fool IDT 1 year ago
The ASX cannabis share hitting fresh highs in 2020

Shares in Cann Group Ltd (ASX: CAN) rose to fresh highs for the year yesterday. The Cann Group share price rose 22.55% during the day to close at $1.68, up significantly from Friday’s close of $1.36. The Cann Group share price has since f...

Motley Fool IDT 1 year ago
NT pot scripts stand at 1 as industry begs govt to act on patient access

Only one prescription for medical marijuana has been issued by a doctor in the Northern Territory, according to Minister for Health Natasha Fyles. In a submission to the Senate inquiry into barriers to patient access to marijuana, Fyles sai...

Stockhead IDT 1 year ago
10 at 10: These ASX stocks are ramping things up this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead IDT 1 year ago
This ASX cannabis share is up 167% in the space of a month

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

Motley Fool IDT 1 year ago
Weed Week: Cannabis munchies not a safe bake

As the world learns tasty cannabis edibles might not be the safest of munchies, Australian investors have served up 19 small cap cannabis stocks as gainers on the ASX. Cannabis edibles are legal in some US states and Canada and just one pro...

Stockhead IDT 1 year ago
Cann Group’s (ASX:CAN) extraction activities underway for medicinal cannabis resin

Cann Group (CAN) and IDT Australia (IDT) have announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin The extracted resin will be used as an active pharmaceutical ingredient to produce GMP me...

themarketherald.com.au IDT 1 year ago
Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market

Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient fo...

SmallCaps IDT 1 year ago
Cannabis: Cann-made marijuana resin could be on the market by March

Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical...

Stockhead IDT 1 year ago
The Cann Group (ASX:CAN) see the first commercial-scale resin extraction for Australia

07 Jan 2020 - The Cann Group (ASX:CAN) and IDT Australia (ASX:IDT) have jointly announced that GMP extraction activities are underway for the first batches of medicinal cannabis re…

FNN IDT 1 year ago
Why cannabis company Cann Group is rocketing 25% higher on Tuesday

The Cann Group Ltd (ASX: CAN) share price has returned from its trading halt and rocketed higher. In morning trade the cannabis company’s shares are up 25% to $1.26. Why is the Cann Group share price rocketing higher on Tuesday? Investors...

Motley Fool IDT 1 year ago
10 at 10: These ASX stocks are looking Golden Globe-worthy this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead IDT 1 year ago
Here’s the bad news some ASX small caps tried to slip past you over Christmas

Few people are at their desks in the week between Christmas and new year, which means it’s a prime dumping period for companies wanting to hide bad news. But there’s always someone who draws the short straw in a newsroom and this year it wa...

Stockhead IDT 1 year ago
Why this ASX cannabis share rocketed 28% higher today

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

Motley Fool IDT 1 year ago
How did these ASX cannabis shares perform in 2019?

This year was a difficult one for ASX cannabis shares as well as cannabis stocks globally with share prices worldwide retreating from previous highs. In Australia the medical marijuana industry remains in its infancy. Nonetheless, the init...

Motley Fool IDT 1 year ago
Health: Invion may have found its break in Chinese dermatology

Invion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. The company told shareholders this morning it signed an MoU with Pavay Biotech, an established provider of dermatology treatment products in...

Stockhead IDT 1 year ago
Can The Pot Stocks Get The Smoke Back; CAN, AC8, THC

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

Kalkine Media IDT 1 year ago
Why this ASX cannabis share crashed 13% lower on Thursday

The AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The medicinal cannabis company’s shares were the worst performers on the All Ordinaries with a decline of 13% to 23.5 cents. Why did the AusCann s...

Motley Fool IDT 1 year ago
Why Cann, Next Science, Service Stream, & Village Roadshow are pushing higher

In afternoon trade the S&P/ASX 200 index is on course to finish the day lower. At the time of writing the benchmark index is down 0.1% to 6,843.6 points. Four shares that have not let that hold them back today are listed below. Here’s...

Motley Fool IDT 1 year ago
THC Global appoints COO at cannabis extraction and manufacturing division

The new COO has more than 30 years’ experience in the pharmaceutical industry in Australia and the UK including roles at PCI Clinical Services, LEO Pharma, IDT Australia, GlaxoSmithKline and Pfizer.

Proactive Investors IDT 1 year ago
Cannabis: Cann Global is entering the African cannabis market

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

Stockhead IDT 1 year ago
Cann Group and IDT Australia prepare for commercial launch of medicinal cannabis product

Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann’s Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new ye...

SmallCaps IDT 1 year ago
10 at 10: These ASX stocks are marching ahead this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead IDT 1 year ago
Why this ASX cannabis share is rocketing 20% higher today

In morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writing the cannabis company’s shares are up 20% to 51 cents. Why is the Cann Group share price rocketing higher? Investors have been buying Can...

Motley Fool IDT 1 year ago
A look at Pot Stocks: CAN versus CGB

In the global medical cannabis market scenario, Australian cannabis market is the fastest one growing in leaps and bounds. The use of cannabis as a pharmaceutical product for the therapy in severe medical conditions such as Alzheimer’s dise...

Kalkine Media IDT 1 year ago
Any Smoke For These Pot Stocks – AGH, THC, AC8, CAN, CGB, MDC

Lately, cannabis stocks in the US have come under pressure, following the rising death toll from vaping that reached 42 so far in 2019, according to media reports. Meanwhile, in Canada, Canopy Growth unveiled that returned cannabis oil prod...

Kalkine Media IDT 1 year ago
Latest In The Emerging Cannabis Space- THC, AGH, CAN, CGB

Cannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after the legalization of cannabis for medicinal as well as recreational purposes. The cannabis industry refers to the activities and all the profe...

Kalkine Media IDT 1 year ago
Why this ASX cannabis share is racing higher on Thursday

The Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade the cannabis company’s shares are up 4% to $1.05. This has reduced its one-month decline to approximately 30%. Why is the Cann Group share p...

Motley Fool IDT 1 year ago
Share Buybacks – Who’s Doing It? – 16-10-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago
A Look at Australian Cannabis Landscape: CAN, AGH, IDT and EXL

Cannabis industry in Australia is growing at a fast pace, and government authorities across the country are creating a lot of prospects for investors by legalising medicinal cannabis. Moreover, it is being assumed that the Australia cannabi...

Kalkine Media IDT 1 year ago
Share Buybacks – Who’s Doing It? – 09-10-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago
Share Buybacks – Who’s Doing It? – 02-10-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago
Share Buybacks – Who’s Doing It? – 25-09-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago
Share Buybacks – Who’s Doing It? – 18-09-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago
Share Buybacks – Who’s Doing It? – 11-09-2019

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

FNArena IDT 1 year ago